WALTHAM, Mass.--(BUSINESS WIRE)--May. 1, 2012--
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving
science, today announced that it has acquired Doe & Ingalls Management,
LLC, a premium provider of specialty production chemicals and customized
supply-chain services to the life sciences and microelectronics
industries, for approximately $175 million in cash. Based in Durham,
North Carolina, Doe & Ingalls operates service centers in key biopharma
and microelectronics hubs in North America. The business generated 2011
revenue of approximately $110 million.
“Doe & Ingalls’ comprehensive line of production chemicals and related
services is highly complementary to our industry-leading channel
capabilities, and will enhance the growth opportunities across both
portfolios,” said Marc N. Casper, president and chief executive officer
of Thermo Fisher Scientific. “Doe & Ingalls will strengthen our value
proposition by adding products and services that address the production
market within our extensive customer base, which we have historically
served primarily from a research perspective.”
Doe & Ingalls’ robust production chemicals portfolio is supported by a
state-of-the-art supply-chain network that serves a large base of
customers in life sciences and advanced technology markets and is ISO
9001:2008 and cGMP compliant. Its MOR™, Smart Sourcing™
and Streamline™ service offerings are specifically designed
to manage risk, quality and total cost in the chemical supply chain
associated with production activities.
Doe & Ingalls will be part of Thermo Fisher’s Customer Channels business
within its Laboratory Products and Services Segment.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving
science. Our mission is to enable our customers to make the world
healthier, cleaner and safer. With revenues of $12 billion, we have
approximately 39,000 employees and serve customers within pharmaceutical
and biotech companies, hospitals and clinical diagnostic labs,
universities, research institutions and government agencies, as well as
in environmental and process control industries. We create value for our
key stakeholders through three premier brands, Thermo Scientific, Fisher
Scientific and Unity™ Lab Services, which offer a unique combination of
innovative technologies, convenient purchasing options and a single
solution for laboratory operations management. Our products and services
help our customers solve complex analytical challenges, improve patient
diagnostics and increase laboratory productivity. Visit www.thermofisher.com.
The following constitutes a “Safe Harbor” statement under the Private
Securities Litigation Reform Act of 1995: This press release contains
forward-looking statements that involve a number of risks and
uncertainties. Important factors that could cause actual results to
differ materially from those indicated by such forward-looking
statements are set forth in the company’s Annual Report on Form 10-K for
the year ended December 31, 2011, under the caption “Risk Factors,”
which is on file with the Securities and Exchange Commission and
available in the “Investors” section of our website under the heading
“SEC Filings.” Important factors that could cause actual results to
differ materially from those indicated by forward-looking statements
include risks and uncertainties relating to: the need to develop new
products and adapt to significant technological change; implementation
of strategies for improving growth; general worldwide economic
conditions and related uncertainties; dependence on customers' capital
spending policies and government funding policies; the effect of
exchange rate fluctuations on international operations; the effect of
healthcare reform legislation; use and protection of intellectual
property; the effect of changes in governmental regulations; and the
effect of laws and regulations governing government contracts, as well
as the possibility that expected benefits related to the acquisitions of
Dionex and Phadia may not materialize as expected. While we may elect to
update forward-looking statements at some point in the future, we
specifically disclaim any obligation to do so, even if estimates change
and, therefore, you should not rely on these forward-looking statements
as representing our views as of any date subsequent to today.
Source: Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
Media Contact Information:
Ron
O’Brien, 781-622-1242
ron.obrien@thermofisher.com
Website:
www.thermofisher.com
or
Investor
Contact Information:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com
